Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

A Phase II multinational clinical trial of brilacidin for the treatment of Ulcerative Proctitis/Ulcerative Proctosigmoiditis (UP/UPS)

Next Previous
Trial Profile

A Phase II multinational clinical trial of brilacidin for the treatment of Ulcerative Proctitis/Ulcerative Proctosigmoiditis (UP/UPS)

Status: Planning
Phase of Trial: Phase II

Latest Information Update: 19 May 2021

Price : $35 *
  • Adis is an information provider.
  • Final gross price and currency may vary according to local VAT and billing address.
  • Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
  • A link to download a PDF version of the trial profile will be included in your email receipt.

At a glance

  • Drugs Brilacidin (Primary)
  • Indications Ulcerative proctitis; Ulcerative proctosigmoiditis
  • Focus Therapeutic Use
  • Sponsors Alfasigma

    • Most Recent Events

    • 13 May 2021 According to an Innovation Pharmaceuticals media release, Alfasigma plans to initiate this trial in 2021. Alfasigma has placed an order with the Company for Brilacidin drug substance needed for the trial.
    • 17 Dec 2019 New trial record
    • 10 Dec 2019 According to an Innovation Pharmaceuticals media release, this trial is expected to begin by mid-year 2020.
Subscriber content

You need to be a logged in subscriber to view this content.

If your organization has a subscription then there are several options available to help you access AdisInsight, even while working remotely.

  • IP authentication when working within your organization’s network.
  • with username/password or try via your institution
  • Persisted access using your organization’s identifier stored in your user browser for 90 days.
  • Contact us at AsktheExpert.AdisInsight@springer.com for assistance.

If your organization does not have a subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Buy a PDF version of the profile.
  • Request a free trial
Legal
Back to top